MyoKardia Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten for Symptomatic, Obstructive Hypertrophic Cardiomyopathy SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of...

Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas Austin, TX, July 31, 2012 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based, emerging biopharmaceutical company developing patient-friendly injectable treatments for diabetes...

The Oregon Idea Commends Legislature for Prioritizing Post-Secondary Education PORTLAND, OR--(Marketwire - Jun 30, 2011) - Before adjourning this week, the Oregon Legislature passed several bills providing funding for post-secondary education and restructuring the Oregon...

Business Community, Alumni of Oregon's Colleges and Universities Call for Reforms and Prioritization of Post-Secondary Education PORTLAND, OR--(Marketwire - January 25, 2011) -  Investing in Oregon's post-secondary education today will lead to economic prosperity tomorrow. That's the message a newly formed coalition of...